Whitehawk Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Whitehawk Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Whitehawk Therapeutics Inc.
Rating: 2.36616675
Author: Trendlyne DVM scores

about

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engine...

1.91 -0.06 (-3.05%)

49.87% Fall from 52W High

129.5K

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Affordable Valuation

54.7 / 100

Technically Neutral

40.0 / 100

1Yr Price target upside is 5%

1 analysts

Whitehawk Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Whitehawk Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engine...

49.87% Fall from 52W High

SWOT Analysis

Whitehawk Therapeutics Inc. Live Price Chart